MAZZEI, TERESITA
MAZZEI, TERESITA
Scienze della Salute (DSS)
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro
1985 Mazzei T, Mini E, Periti P
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells
1987 Bernabei PA, Mini E, Agostino FC, Gattei V, Bezzini ER, Santini V, Saccardi R, Mazzei T, Rossi Ferrini P
[Beta-lactam antibiotics: when and how in acute otitis media and pharyngotonsillitis]
2007 G. Schito; P. Marchisio; L. Bellussi; T. Mazzei
[Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies]
2001 A. Martoni; E. Mini; C. Pinto; A. Gentile; T. Mazzei
[Plasma and tissue antibiotic concentrations: what is their prognostic value?]
1992 Mazzei, T; Novelli, A; Mini, E; Periti, P
A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion
1993 Periti P, Stringa G, Mazzei T, Mini E, Novelli A, Calviani L
A randomized multicenter study comparing 5-fluorouracil (5-FU) and l-folinic acid (L-LV) alone or with levamisole (LEV) or interferon alpha2a (IFNalpha2a) as adjuvant therapy for colorectal cancer
1996 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P
A survey on infection management practices in Italian ICUs
2012 Bassetti M; De Gaudio R; Mazzei T; Morace G; Petrosillo N; Viale P; Bello G; La Face S; Antonelli M
A survey on infection management practices in Italian ICUs.
2012 Bassetti M;De Gaudio R;Mazzei T;Morace G;Petrosillo N;Viale P;Bello G;La Face S;Antonelli M
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
2016 Mini, E; D’Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Tassi, R; Napoli, C; Picariello, L; Landini, I; Brugia, M; Mazzei, T; Tonelli, F; Nobili, S
Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU)
1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Nobili S, Mazzoni P
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI)
1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano.
1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P, Dentico P
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or with levamisole (LEV) or interferon alpha2a (IFN alpha2a).
1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI)
1996 T. Mazzei; E. Mini; P. Mazzoni; F. Ficari; P. Periti; F. Tonelli; and other participants of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI)
ADVANCED COLORECTAL CANCER (ACRC) IN ELDERLY PATIENTS: EVALUATION OF THREE DIFFERENT OXALIPLATIN-BASED CHEMOTHERAPY REGIMENS - Session D: Colo-rectal Cancer
2005 Pinto C, Di Fabio F, Gentile AL, Mini E, Giaquinta S, Rojas Llimpe FL, Mutri V, Piana E, Mazzei T, Martoni A
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study
2017 Nobili S, Mini, E, Mazzei T, Vannacci A
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study
2017 Galiulo M, Convertino I, Blandizzi C, Tassi R, Diacciati S, Nobili S, Capogrosso Sansone A, Marino A, Mini E, Mazzei T, Vannacci A, Parrilli M, Corona T, Tuccori M
Adverse effects of macrolide antibacterials.
1993 P. Periti; T. Mazzei; E. Mini; A. Novelli
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
1976 T. Mazzei; M. Paradiso; I. Nicoletti; P. Periti